Balanced Coverage

FDA approves first cervical cancer screening device that can be used at home, company says



20% left coverage14% right coverage

The Food and Drug Administration approved the Teal Wand, the first at-home cervical cancer screening test, allowing women to collect samples with a vaginal swab and mail them to a lab for testing. Cervical cancer is highly preventable, but the American Cancer Society states that nearly half of patients were not up-to-date on screenings before diagnosis.

Teal Health plans to start shipping the Teal Wand to California residents aged 25 to 65 in June 2025, aiming for nationwide availability soon after.

The at-home test could improve screening access, especially for women in rural areas, where cervical cancer diagnosis and mortality rates are higher, according to recent research from JAMA Network Open.

Discover reporting you’re not seeing from biased, mainstream media outlets.

Using our real-time Media Miss™ tool powered by Ground News, we spotlight stories that right-leaning and left-leaning news outlets aren’t covering to bring you a complete picture of the news.

Learn more about how Media Miss™ works.

Media Landscape

Click on bars to see headlines

71 total sources

Key points from the Center

No summary available because of a lack of coverage.

Report an issue with this summary

Other (sources without bias rating):

Powered by Ground News™